Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

For patients with MCI associated with Alzheimer disease, those in the highest tertile of the triglyceride-glucose index experience faster cognitive decline.

Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...

Dementia prevalence in India is rising, with experts emphasizing comprehensive evaluations, reversible causes, and global therapy advances.

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study ...